Celldex Therapeutics Shares Down 44.6% Since SmarTrend's Sell Call (CLDX)

SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on July 27th, 2015 at $23.92. In approximately 2 months, Celldex Therapeutics has returned 44.60% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.